Researchers have identified azelaic acid as a potential therapeutic agent against leukemia cutis by inhibiting the trafficking of acute myeloid leukemia cells to the skin. The study uncovers molecular mechanisms underlying skin infiltration characteristic of this aggressive manifestation, offering a novel intervention pathway with azelaic acid’s antioxidant properties. This discovery provides groundwork for developing treatments targeting leukemic skin involvement, a complication associated with poor prognosis.